HIGHLIGHTS
- who: Chen Fang and collaborators from the Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China have published the research: PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury, in the Journal: Biomolecules 2022, 11, x FOR PEER REVIEW of 15/08/2022
- what: This study investigated the characteristics of PAGln in AF patients and its impact on atrial myocytes. The authors analyzed the alteration in the relative abundance of porA, a critical gut microbial synthesis enzyme of PAGln , based on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.